Novel insights into disseminated candidiasis: Pathogenesis research and clinical experience converge

PLoS Pathogens

Volumn 4, Issue 2, 2008, Pages

  Spellberg, Brad ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; DEXTRAN SULFATE; FLUOROURACIL; METHOTREXATE;

BLOOD FLOW; CANDIDA ALBICANS; DISEASE PREDISPOSITION; FUNGAL COLONIZATION; FUNGUS GROWTH; GASTROINTESTINAL MUCOSA; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INVASIVE CANDIDIASIS; KIDNEY; KIDNEY INFECTION; LIVER; LYMPHOCYTE; NEUTROPENIA; NONHUMAN; NOTE; RISK FACTOR; ANIMAL; ARTICLE; BACTERIAL TRANSLOCATION; CANDIDA; CANDIDIASIS; DISEASE MODEL; IMMUNOLOGY; INTESTINE MUCOSA; MICROBIOLOGY; MOUSE; OPPORTUNISTIC INFECTION; PATHOGENICITY; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; RESEARCH; SEPSIS; SKIN; VIRULENCE;

ANIMALS; BACTERIAL TRANSLOCATION; CANDIDA; CANDIDIASIS; DISEASE MODELS, ANIMAL; INTESTINAL MUCOSA; MICE; OPPORTUNISTIC INFECTIONS; PHAGOCYTOSIS; RESEARCH; SEPSIS; SKIN; VIRULENCE;

EID: 40349100417     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0040038     Document Type: Note

References (12)

1. Perlroth J, Choi B, Spellberg B (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45: 321-346.
2. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB (2008) Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 4:: e35. doi:10.1371/journal.ppat.0040035
3. Clemons KV, Espiritu M, Parmar R, Stevens DA (2006) Assessment of the paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob Agents Chemother 50: 1293-1297.
4. MacCallum DM, Odds FC (2005) Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48: 151-161.
5. Spellberg B, Ibrahim AS, Edwards JE Jr, Filler SG (2005) Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 192: 336-343.
6. Leunk RD, Moon RJ (1979) Physiological and metabolic alterations accompanying systemic candidiasis in mice. Infect Immun 26: 1035-1041.
7. Papadimitriou JM, Ashman RB (1986) The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol 150: 257-265.
8. Cole GT, Halawa AA, Anaissie EJ (1996) The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22 Suppl 2: S73-S88.
9. Clemons KV, Gonzalez GM, Singh G, Imai J, Espiritu M, et al. (2006) Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob Agents Chemother 50: 2650-2657.
10. Ashman RB, Papadimitriou JM, Fulurija A, Drysdale KE, Farah CS, et al. (2003) Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb Pathog 34: 103-113.
11. Jensen J, Warner T, Balish E (1993) Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis 167: 912-919.
12. Spellberg BJ, Johnston D, Phan QT, Edwards JE Jr, French SW, et al. (2003) Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis. Infect Immun 71: 5756-5764.